fI

ITI-

tElF
\Section

MarnRrAL S,lrnryDnr.l SHnrr

I - Chemical Product and Company ldentification

MSDS Name
Synonyms

Companyldentification

L-(+)-Ascorbic acid
Vitamin C
NortheastGeneralPharmaceuticalFactory
No. 37, ZhonggongBei Street

Tiexi District
Shenyang

Liaoning
P.R. China
110026

- Composition, Infomation on: fngredients o/o

CAS#
Chemical Name
50-81-7
L-(+)-Ascorbic acid
100%

Section 2

EINECS#
200-066-2

Section 3 -Hazards ldentification

EMERGENCY OVER\/IEW
Light sensitive, Air sensilive.

POTENTIAL HEALTIJI EFFECTS

Eye
Skin

Ingestion
Inhelation

Chronic

Contact rray cause transient eye initation.

Low hazard for usual industrial handling.
Low hazard for usual industrial handling. May cause mild digestive tract irritation.
May cause respiratory tract irritation.
Not avail:61e.

Section 4 - First aid Measures

Eyes

Iflush eyes with plenty of water for at least 15 minutes, occasionally lifting the
upper and lower lids. Get medical aid.

Skin

Itlush skin with plenty of soap and water for at least 15 minutes while
removing contaminated clothing and shoes. Get medical aid if initation

Ingestion
Inhalation

Get medical aid. Wash mouth out with water.

Remove from exposure to fresh air immediately. If not breathing, give artificial
respiration. If breathing is difficull give oxygen.
Get medical aid if cough or other symptoms appear.
:freat symptomatically and

Notes to

Physician

clevelops or persists.

Section 5 - Fire Fighting Measures

Information As in any fire, wear a self-contained breathing appararus in pressuredemand, MSHANIOSH (approved or equivalent), and full protective

General

Extinguishing

Media

Eear.

In

case

of fire use water spray, dry chemical, carbon dioxide,

chemical foam.

Autoignition Temperature Notavailable.

F'lash

Point
Rating
Limits

NFPA
Explosion

Not available.
Not published.
Lower: Not available.
Upper: Not available.

Section 6 - Accidental Releese Measures

General

Information

Spills/Leaks

Use proper personal protective equipment as indicated in Section 8.

Vacuum or sweep up material and place into a suitable disposal container.

or

Section 7 - Handling and Storage

Avoid breathing dust, vapor, mist, or gas. Avoid contact u'ith skin and eyes.
Handling
Stored in a cool, dry place. Stored in a tightly closed container.
Storage
Section 8 - Exposure Controls, Personal Protection
Engineering

Controls

Use adequate ventilation to keep airborne concenhations low.

PERSONAL PROTECI'IVE EQUIPMENT

Eyes

Wear appropriate protective eyeglasses or chemical safety goggles as described by

Skin
Clothing

OSHA's eye and face protection regulations

Standard ENl55.

in 29 CFR

1910.

133

or

European

Wear appropriate protective gloves to prevent skin exposure.

Wear appropriate protective clothing to prevent skin exposure.

Respirators Follow the OSHA respirator

in 29CFR 1910.134 or European

or European Standard EN 149 approved

regulations found

Standard EN 149. Always use a NIOSH

respirator when necessary.

Section 9 - Physical and Chemieal Properties

Powder

Physical State
Appearsnce

White
Not available.
Not available.
Negligible.
Not available.
Not available.
190 0c

Odor
pH
Vapor Pressure
Viscosity

Boiling Point
Freezing/IVlelting Point

DecompositionTemperature Notavailable.
333 glL water at 20oC
1.7000 g/cm'
C6Hs06
176.13

Solubility
Specific Gravity/DensitY
Molecular Formula
Molecular Weight

Section 10 - Stability and Reactivity

Chemical Stability
Conditions to Avoid

Incompatibilities with Other

Materials

Products
Polymerization

Hazardous Decomposition
Hazardous

Stable under normal temperatures and pressures.

Incompatible materials, light, exposure to air.
Strong oxidizing agents
Carbon monoxide, carbon dioxide
Will not occur

Section 11 - Toricological Information

RTECS#
LDso/LCs0

CAS# 50'EI-7: C17650000

CAli# 50-81-7: Oral, mouse: LDso = 3367 mgkg; Oral, rat: LD:o = I 1900 mg/kg'

Carcinogenicity L-(r-)-Ascorbic

Other

See actual

acid, Not listed by ACGIH, IARC, NIOSH. NTP, or OSHA,

enW in RTECS for complete information

Section 12 - Ecotogical Information

For further information, contact Northeast General Pharmaceutical Factory.

Section 13 - Disposal Consideretions

Dispose of in a manner consistent with local regulations.

Section 14 - Transport Information

US

Shipping Name:

Hazard Class:
UN Number:
Packing GrouP:

DOT IMO

NiA

IATA

RID/ADR
-

Canadian TDG
N/A

Section 15 - ReEulatory Informafion

European/lntemational Regulations
European Labeling in Acc,rrdance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:

524125 Avoid contact with skin and eyes.

WGK (Water Danger/Protection)
CAS# 50-81-7: 0
Canada

CAS# 50-81-7 is listed on Canada's DSLNDSL List.

CAS# 50-81-7 is not listecl on Canada's Ingredient Disclosure List.
Exposure Limits
US FEDERAL

TSCA
CAS# 50-81-7 is listed on the TSCA inventory.

Section f6 - Additional Information

The information above is believed to be accurate and represents the best information currently available
to us. However, we make no wananty of merchantability or any other warranty, express or implied,
with respect to such information, and we assume no liability resulting from its use. Users should make
their own investigations to determine the suitability of the information for their particular purposes. In
no way shall the company be liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary darnages, howsoever arising,
even ifthe company has been advised of the possibility of such damages.